Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 27 announcements

Share price: ₹2,520.30
Market cap: ₹19,157 Cr
Revenue (annual): ₹2,187 Cr
Net profit (annual): ₹641.2 Cr
P/E (TTM): 28.8×Sector 43.8×
Promoter holding: 70.57%+0.00% QoQ
FII holding: 5.72%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 5 Earnings Call 4 Financial Results 3 Board Meeting Date 3 Regulatory Approval 2 Price Movement Clarification 2 Dividend 2 Business Update 2 Annual General Meeting 2 Management Change 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

2 Nov 2026 17:52 IST BSE

Board Meeting Date

Caplin Point Laboratories Board Meeting Date

Caplin Point schedules a 12 November 2026 board meeting for unaudited quarterly and half-year results. The trading window stays closed until 14 November 2026.

Open announcement → Read the filing ↗

29 Jul 2026 16:39 IST BSE

Board Meeting Date

Caplin Point Laboratories Board Meeting Date

Caplin Point Laboratories will hold a board meeting on August 12, 2026, to consider quarterly financial results and recommend a final dividend for FY 2025-26.

Open announcement → Read the filing ↗

7 May 2026 16:06 IST BSE

Board Meeting Date

Caplin Point Laboratories Board Meeting Date

Caplin Point Laboratories Ltd has scheduled a Board Meeting on May 14, 2026. The board will consider audited financial results for FY2026 and a potential interim dividend for FY2025-26. The company's trading window remains closed until May 16, 2026.

Open announcement → Read the filing ↗